Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
U Hess
Observed names:
U. Hess,
Uwe Hess
Institution:
Kantonsspital St. Gallen
Observed institutions:
Goethe University Frankfurt,
Kantonsspital St. Gallen,
Rigshospitalet,
Medizinische Hochschule Hannover
OpenAlex ID:
A5068100722
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
1997
·
B Löwenberg
, M A Boogaerts
, et al.
·
Journal of Clinical Oncology
·
131
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony- stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study
1992
·
A Ganser
, A Lindemann
, et al.
·
Blood
·
75
PDF
Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes.
1993
·
A Ganser
, O G Ottmann
, et al.
·
PubMed
·
45
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)
2008
·
R. Zenhausern
, M. Simcock
, et al.
·
Haematologica
·
42
PDF
Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
1994
·
A Ganser
, G Seipelt
, et al.
·
PubMed
·
42
MYELOKATHEXIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (rhGM‐CSF)
1992
·
U. Hess
, A. Ganser
, et al.
·
British Journal of Haematology
·
32
Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.
1992
·
A Ganser
, G Seipelt
, et al.
·
PubMed
·
23
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
2014
·
Margriet Oosterveld
, Stefan Suciu
, et al.
·
Annals of Hematology
·
14
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemia
2006
·
S Meyer-Monard
, V Parlier
, et al.
·
Leukemia
·
14
Clinical Evaluation of Interleukin-3
1992
·
A. Ganser
, O. G. Ottmann
, et al.
·
Springer eBooks
The Therapeutic Effect of Recombinant Human Cytokines (GM-CSF, Interleukin-3, Erythropoietin) in Patients with Myelodysplastic Syndromes
1992
·
A. Ganser
, M. Eder
, et al.
·
Springer eBooks
Effect of Interleukin-3 on Human Hematopoietic Progenitor and Precursor Cells in Patients with Myelodysplastic Syndromes
1992
·
U. Hess
, A. Ganser
, et al.
·
Springer eBooks
Preclinical and clinical evaluation of interleukin 3.
1991
·
A Ganser
, O G Ottmann
, et al.
·
PubMed
Show more works
View as search
Works count:
13
Citation count:
418
H-index:
9
I10-index:
9
Year
Topic
Type